Skip to Content

COVID-19 Info: Please help us slow the spread of coronavirus - Wear a Mask, Wash Your Hands & Wait 6 Feet Apart!
Visitor Policies and Precautions | COVID-19 Testing| Vaccine information | Commitment to Safety | Current Numbers

Clinical Trials Details

Merck MK7902-007

Patient Information

A Phase 3, randomized, double-blind trial of pembrolizumab (MK-3475) with or without lenvatinib (E7080/MK-7902) in participants with treatment-naïve, metastatic non-small cell lung cancer (NSCLC) whose tumors have a tumor proportion score (TPS) greater than or equal to 1%.

Learn more about clinical trial: Merck MK7902-007

Clinical Trial Categories

  • Lung Cancer - Metastatic

Location

  • Cone Health Cancer Center at Alamance Regional
    1236 Huffman Mill Rd.
    Burlington, NC 27215
    Main: 336-538-7725
  • Cone Health Cancer Center at Wesley Long
    2400 W. Friendly Avenue
    Greensboro, NC 27403
    Main: 336-832-1100